149 related articles for article (PubMed ID: 9510849)
1. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders.
Costa CG; Dorland L; Holwerda U; de Almeida IT; Poll-The BT; Jakobs C; Duran M
Clin Chem; 1998 Mar; 44(3):463-71. PubMed ID: 9510849
[TBL] [Abstract][Full Text] [Related]
2. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified.
Jones PM; Burlina AB; Bennett MJ
J Inherit Metab Dis; 2000 Nov; 23(7):745-50. PubMed ID: 11117435
[TBL] [Abstract][Full Text] [Related]
3. Plasma free fatty acids in mitochondrial fatty acid oxidation defects.
Martínez G; Jiménez-Sánchez G; Divry P; Vianey-Saban C; Riudor E; Rodés M; Briones P; Ribes A
Clin Chim Acta; 1997 Nov; 267(2):143-54. PubMed ID: 9469249
[TBL] [Abstract][Full Text] [Related]
4. Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders.
Onkenhout W; Venizelos V; van der Poel PF; van den Heuvel MP; Poorthuis BJ
Clin Chem; 1995 Oct; 41(10):1467-74. PubMed ID: 7586519
[TBL] [Abstract][Full Text] [Related]
5. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
7. Rapid diagnosis of medium-chain acyl CoA dehydrogenase deficiency by measurement of cis-4-decenoic acid in plasma.
Heales SJ; Woolf DA; Robinson P; Leonard JV
J Inherit Metab Dis; 1991; 14(5):661-7. PubMed ID: 1779611
[TBL] [Abstract][Full Text] [Related]
8. A sensitive and simplified method to analyze free fatty acids in children with mitochondrial beta oxidation disorders using gas chromatography/mass spectrometry and dried blood spots.
Kimura M; Yoon HR; Wasant P; Takahashi Y; Yamaguchi S
Clin Chim Acta; 2002 Feb; 316(1-2):117-21. PubMed ID: 11750281
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
10. Long-chain fatty acid oxidation during early human development.
Oey NA; den Boer ME; Wijburg FA; Vekemans M; Augé J; Steiner C; Wanders RJ; Waterham HR; Ruiter JP; Attié-Bitach T
Pediatr Res; 2005 Jun; 57(6):755-9. PubMed ID: 15845636
[TBL] [Abstract][Full Text] [Related]
11. Improved stable isotope dilution-gas chromatography-mass spectrometry method for serum or plasma free 3-hydroxy-fatty acids and its utility for the study of disorders of mitochondrial fatty acid beta-oxidation.
Jones PM; Quinn R; Fennessey PV; Tjoa S; Goodman SI; Fiore S; Burlina AB; Rinaldo P; Boriack RL; Bennett MJ
Clin Chem; 2000 Feb; 46(2):149-55. PubMed ID: 10657369
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of 3-hydroxy-fatty acids in the culture medium of long-chain L-3-hydroxyacyl CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein-deficient skin fibroblasts: implications for medium chain triglyceride dietary treatment of LCHAD deficiency.
Jones PM; Butt Y; Bennett MJ
Pediatr Res; 2003 May; 53(5):783-7. PubMed ID: 12621125
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood.
Rocchiccioli F; Wanders RJ; Aubourg P; Vianey-Liaud C; Ijlst L; Fabre M; Cartier N; Bougneres PF
Pediatr Res; 1990 Dec; 28(6):657-62. PubMed ID: 2284166
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
15. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of 3-hydroxy fatty acid analysis by gas chromatography-mass spectrometry.
Jones PM; Bennett MJ
Biochim Biophys Acta; 2011 Nov; 1811(11):657-62. PubMed ID: 21745593
[TBL] [Abstract][Full Text] [Related]
18. Chemical diagnosis of inherited defects of fatty acid metabolism and ketogenesis.
Duran M; Wadman SK
Enzyme; 1987; 38(1-4):115-23. PubMed ID: 3326728
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial very long chain acyl-CoA dehydrogenase deficiency--a new disorder of fatty acid oxidation.
Largillière C; Vianey-Saban C; Fontaine M; Bertrand C; Kacet N; Farriaux JP
Arch Dis Child Fetal Neonatal Ed; 1995 Sep; 73(2):F103-5. PubMed ID: 7583594
[TBL] [Abstract][Full Text] [Related]
20. Determination of total fatty acids in plasma: cis-5-tetradecenoic acid (C14:1 omega-9) in the diagnosis of long-chain fatty acid oxidation defects.
Divry P; Vianey-Saban C; Mathieu M
J Inherit Metab Dis; 1999 May; 22(3):286-8. PubMed ID: 10384388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
